A detailed history of Physicians Financial Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Physicians Financial Services, Inc. holds 11,885 shares of ABBV stock, worth $2.22 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
11,885
Previous 12,260 3.06%
Holding current value
$2.22 Million
Previous $1.9 Million 13.89%
% of portfolio
0.76%
Previous 0.72%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $59,932 - $68,287
-375 Reduced 3.06%
11,885 $2.16 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $4,637 - $5,771
-35 Reduced 0.28%
12,260 $1.65 Million
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $93,947 - $107,751
-700 Reduced 5.39%
12,295 $1.65 Million
Q2 2022

Aug 17, 2022

BUY
$137.62 - $174.96 $92,893 - $118,098
675 Added 5.48%
12,995 $1.99 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $11,878 - $14,737
-90 Reduced 0.73%
12,320 $2 Million
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $14,503 - $18,350
-135 Reduced 1.08%
12,410 $1.68 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $22,131 - $25,122
-208 Reduced 1.63%
12,545 $1.35 Million
Q2 2021

Jul 27, 2021

SELL
$105.21 - $117.21 $69,438 - $77,358
-660 Reduced 4.92%
12,753 $1.44 Million
Q1 2021

May 21, 2021

BUY
$102.3 - $112.62 $951,901 - $1.05 Million
9,305 Added 226.51%
13,413 $1.45 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $38,232 - $51,618
475 Added 13.07%
4,108 $440,000
Q2 2020

Jul 28, 2020

BUY
$73.37 - $98.18 $58,696 - $78,544
800 Added 28.24%
3,633 $357,000
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $6,570 - $8,398
100 Added 3.66%
2,833 $206,000
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $212,764 - $262,395
2,733 New
2,733 $252,000
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $251,647 - $336,979
-2,735 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $191,039 - $244,016
2,735
2,735 $243,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $330B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Physicians Financial Services, Inc. Portfolio

Follow Physicians Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Physicians Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Physicians Financial Services, Inc. with notifications on news.